Actinium Pharmaceuticals (ATNM) EPS (Basic) (2010 - 2026)
Actinium Pharmaceuticals (ATNM) posted quarterly EPS (Basic) of -$0.18 for Q1 2026, up 64.48% year-over-year from -$0.11 in Q1 2025, and up 6.5% quarter-over-quarter from -$0.2 in Q4 2025.
Actinium Pharmaceuticals (ATNM) EPS (Basic) (2010 - 2026) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported EPS (Basic) for 17 consecutive years, with -$0.18 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 64.48% year-over-year to -$0.18; the TTM figure through Mar 2026 stood at -$0.8 (up 55.57% YoY), while the FY2025 annual figure was -$1.07, up 16.1% from the prior year.
- EPS (Basic) rose to -$0.18 in Q1 2026 per ATNM's latest filing, from -$0.2 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.18 in Q1 2026 and bottomed at -$0.76 in Q1 2024.
- Historically, EPS (Basic) has averaged -$0.41 across 5 years, with a median of -$0.38 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) plunged 102.24% — and 2025, when it jumped 69.28%.
- Actinium Pharmaceuticals' EPS (Basic) stood at -$0.47 in 2022, then increased by 24.17% to -$0.36 in 2023, then jumped by 36.44% to -$0.23 in 2024, then rose by 13.44% to -$0.2 in 2025, then grew by 6.5% to -$0.18 in 2026.
- Business Quant data shows ATNM's EPS (Basic) at -$0.18 in Q1 2026, -$0.2 in Q4 2025, and -$0.2 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Actinium Pharmaceuticals | 34.85 Mn | 34.85 Mn | - | 0.89 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.89 |
| Mar 31, 2026 | -0.18 |
| Dec 31, 2025 | -0.20 |
| Sep 30, 2025 | -0.20 |
| Jun 30, 2025 | -0.22 |
| Mar 31, 2025 | -0.52 |
| Dec 31, 2024 | -0.23 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | -0.72 |
| Mar 31, 2024 | -0.76 |
| Dec 31, 2023 | -0.36 |
| Sep 30, 2023 | -0.55 |
| Jun 30, 2023 | -0.58 |
| Mar 31, 2023 | -0.46 |
| Dec 31, 2022 | -0.47 |
| Sep 30, 2022 | -0.60 |
| Jun 30, 2022 | -0.33 |
| Mar 31, 2022 | -0.24 |
| Dec 31, 2021 | -0.39 |
| Sep 30, 2021 | -0.30 |